Clinical Research News Online
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • Press Releases
    • Post Press Releases
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Recorded Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • Clinical Trainings
    • Clinical Conferences
    • Clinical Trial Innovation Summit
    • Barnett International
  • About
    • Editorial Calendar
    • Editorial Profile
    • Contact Us
    • Submit a Story
  • SCOPE Summit
    • SCOPE Summit – US
    • SCOPE Summit – Europe
    • European Innovations Awards
 
 
 
 
  • Serious Risks About Existing Drugs Aren’t Given to Trial Participants

    Pharmalot | New research finds some serious risks are not disclosed on consent forms given to trial participants for studies involving approved drugs.

    Jul 29, 2015
  • Not All Fake Medicines Are Created Equal

    Washington Post | As more studies confirm that different placebos may have stronger or weaker placebo effects, scientists raise questions about how to compare the efficacy of real drugs across trials that used varying placebos.

    Jul 28, 2015
  • HelpAround Explores the Social Aspects of Mobile Health

    Clinical Informatics News | With stripped-down mHealth apps like Alert and Diabetes Helpers, Tel Aviv-based HelpAround wants to use the real-time data and location tracking of mobile technology to tap into chronic disease patients' own social networks.

    Jul 27, 2015
  • Faulty Bioequivalence Studies Lead to Hundreds of Drug Suspensions in Europe

    WSJ Pharmalot | The European Union has accepted a recommendation to suspend hundreds of drugs that were authorized for use based on what regulators called "flawed" studies conducted by GVK Biosciences, a clinical research organization based in Hyderabad, India.

    Jul 27, 2015
  • GlaxoSmithKline Sues Tibco Software Over Risk Monitoring Software

    Triangle Business Journal | ​GlaxoSmithKline has accused a California-based software developer of violating federal copyright law by selling a custom software package that was allegedly created in partnership with GSK.

    Jul 22, 2015
  • Made-In-Singapore Cancer Drug Advances To Clinical Trials

    Asian Scientist Magazine | ETC-159, a Wnt-targeting anti-cancer drug indicated for colorectal, ovarian and pancreatic cancers, has entered a Phase I clincial trial.

    Jul 20, 2015
  • HIPAA’s Use as Code of Silence Often Misinterprets the Law

    New York Times | The protection of a patient's health information does not prohibit health care providers from sharing information with family, friends and caregivers.

    Jul 17, 2015
  • FDA Grants Blueprint Go-Ahead for Kinase Inhibitor Trials

    Xconomy | Blueprint Medicines got the green light from the Food and Drug Administration to begin clinical trials on its two lead drug candidates for cancer, about two months after its IPO.

    Jul 13, 2015
  • After Celgene Deal Juno Revs Armored CAR For Ovarian Cancer Trial

    Xconomy | Juno Therapeutics has built remarkable momentum and is about to launch the first trial in humans of engineered T cells.

    Jul 10, 2015
  • Concerns and Skepticism Around 21st Century Cures Act

    Washington Post | While some measures in the bipartisan 21st Century Cures Act, like increased NIH funding, have attracted widespread praise, other measures threaten to weaken the safety and efficacy evidence needed for drugs to pass muster with the FDA.

    Jul 10, 2015
  • Do No Harm

    Vox | An investigation into heart line catheter infections reveals the harm analysis strategies that let hospitals prevent deadly medical errors.

    Jul 9, 2015
  • Hospital ICUs Mine Big Data in Push for Better Outcomes

    WSJ | Leading hospitals such as Beth Israel Deaconess Medical Center in Boston and Johns Hopkins Medicine in Baltimore look for clues in the wealth of information from past cases.

    Jul 9, 2015
  • Consulting Merger Creates Certara Strategic Consulting

    Clinical Informatics News | Certara has merged its consulting group, Pharsight Consulting Services (PCS), with Quantitative Solutions, a global pharmacometrics consulting company headquartered in Menlo Park, Calif. forming Certara Strategic Consulting. Jaap Mandema, former CEO of Quantitative Soutions, will serve as the new head of Certara Strategic Consulting. Financial details were not disclosed.

    Jul 8, 2015
  • UCSD Asks Court to Restore Custody and Control of Alzheimer’s Data

    Xconomy | In the recent donnybrook between UC San Diego and the University of Southern California, the 24-year old Alzheimer's Disease Cooperative Study is what's at stake.

    Jul 8, 2015
  • World Health Organization Scolds Indian Company for Clinical Trial Violations

    WSJ | Yet another contract research organization in India is being scolded for its handling of clinical trial records.

    Jul 7, 2015
  • «
  • 241
  • 242
  • 243
  • 244
  • 245 (current)
  • 246
  • 247
  • 248
  • 249
  • 250
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy